Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Penpulimab (Anti-Pd-1) Combined With Anlotinib As First-Line Therapy For Unresectable Hepatocellular Carcinoma (Uhcc): Updated Results From A Phase Ib/Ii Study.

Shun Chang Jiao,Li Bai,Jiahong Dong,Chunmei Bai,Chunhong Hu,Liangfang Shen,Qun Qin,Yuxian Bai,Jia Fan,Aimin Zang,Yanyun Zhu,Chun Han,Juan Li,Pengfei Zhang,Sisi Ye,Xindan Kang,Qian Qiao,Zhongmin Maxwell Wang,Baiyong Li,Yu Xia

JOURNAL OF CLINICAL ONCOLOGY（2021）

Cited 2|Views43
No score
Abstract
306Background: Combined therapy of an immune checkpoint inhibitor with a targeted antiangiogenic agent had been proved to be effective for the treatment of uHCC. Penpulimab was engineered to elimin...
More
Translated text
Key words
hepatocellular carcinoma,unresectable hepatocellular carcinoma,anlotinib,first-line
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined